医疗机构中的风险药品 (MAR)：实施策略、沟通和机构影响

{"title":"医疗机构中的风险药品 (MAR)：实施策略、沟通和机构影响","authors":"C. Duvette, S. Bost-Bonnet, J. Perez, F. Poirot-Lutrin, A. Mouffak, N. Lathuraz, M. Ducret, E. Pineau-Blondel","doi":"10.1016/j.phacli.2024.04.395","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508818,"journal":{"name":"Le Pharmacien Clinicien","volume":"60 12","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Médicaments a risque (MAR) en établissement de santé : stratégie de mise en place, communication et impact institutionnel\",\"authors\":\"C. Duvette, S. Bost-Bonnet, J. Perez, F. Poirot-Lutrin, A. Mouffak, N. Lathuraz, M. Ducret, E. Pineau-Blondel\",\"doi\":\"10.1016/j.phacli.2024.04.395\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":508818,\"journal\":{\"name\":\"Le Pharmacien Clinicien\",\"volume\":\"60 12\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Le Pharmacien Clinicien\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.phacli.2024.04.395\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Le Pharmacien Clinicien","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.phacli.2024.04.395","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}